Previous studies showed that SP1 can modulate many lncRNAs like LINC00673120, SPRY4-IT1121, LUCAT1122, and FTH1P3123 in a variety of malignancies in addition to breast cancer. This evidence concerns the gene SP1 and breast carcinoma.